| Similar Articles |
|---|
 |
The Motley Fool
February 28, 2005
Rich Smith |
Possis Medical in Critical Condition Six months after a clinical study first questioned the effectiveness of its AngioJet blood clot-clearing system, Possis Medical remains a company in shock. Investors, take note.   |
The Motley Fool
August 22, 2005
Rich Smith |
Possis' Possible Pitfalls The medical device maker reaffirms earlier guidance, but it's still not enough to justify the stock price. |
The Motley Fool
September 17, 2004
Rich Smith |
The Positive Side of Possis Check on the valuation of the medical device maker's badly wounded stock, based on latest earnings. |
The Motley Fool
May 25, 2006
Rich Smith |
Can Possis Recover? Predicted by itself to make at least $15.5 million in sales, Possis Medical reported instead just $15.2 million. As a result, the company's stock has already fallen 10% as of this writing. That's just the beginning of the bad news. |
The Motley Fool
May 19, 2004
Rich Smith |
Possis Flush With Profits This company does one thing and does it very well. Sales of its AngioJet catheter system make up 98% of the company's revenues. |
The Motley Fool
November 23, 2005
Rich Smith |
Possis Poses Problems The price is still too high as growth continues to slow at the medical device maker. |
